TERMINUS.
COMPOUNDS / GROWTH HORMONE FRAGMENTS

aod-9604

Growth hormone fragments · 4 suppliers · $7.00 to $20.00 per mg · 0 registered studies · 16 indexed papers

This page holds two records that were compiled separately. The research figures below come from the public registries named under each one, each read on the date printed beside it. The supplier prices at the foot were read on the suppliers own sites on the dates in that table. Nothing here was produced by this publication measuring anything.

Identity and computed properties

PubChem holds this compound as CID 71300630, molecular formula C78H123N23O23S2, average mass 1815.1 daltons and monoisotopic mass 1813.8604 daltons, read on 2026-09-19. Those masses are computed from the deposited structure and were not measured on any material, so they are the expected value an identity check compares against rather than evidence about any vial.

The title that record carries for the CID is Aod-9604. Its synonym list runs to 19 entries. Among them: AOD 9604 and AOD9604.

Receptors the literature describes

No published paper this search reached describes a receptor this compound acts at.

The registered trial record

No study naming this compound is registered on clinicaltrials.gov. The intervention term searched on 2026-09-19 was AOD-9604.

Registry counts measure registration, not knowledge.

The publication record

PubMed answered 16 records for the term AOD-9604 on 2026-09-19. None of the 16 carries a clinical-trial publication type. 6 carry the publication type Review, which is other people reading the rest.

PubMed counts measure indexing, so work in venues it does not index is invisible to this figure. The term that produced it is printed above so it can be run again.

Regulatory status

A Drugs@FDA query on 2026-09-19 returned no application record for any of these 9 searches:

This compound is a modified piece of human growth hormone, not the hormone itself. The full-length protein is approved under the name somatropin, which returned five applications on a Drugs@FDA search on 2026-09-19. This compound returned nothing under any of the three AOD spellings searched above on the same day. The approvals belong to the protein, not to this fragment. One more thing a reader checking the PubChem record should know: that record lists Tyr-somatostatin (177-191) among its synonyms. Somatostatin is a different hormone from growth hormone, so that synonym does not belong to this compound and is not used anywhere on this page.

Findings, as published reports recorded them

This block was compiled and no finding from a named publication was reached.

Adverse events, as published reports recorded them

This block was compiled and no adverse event from a named publication was reached.

Spontaneous report databases are not used on this page. A count of reports carries no denominator, so it cannot be read as a rate and is not printed as one.

Who it is not given to

No doctor prescribes this. There is no approved product under this name on the Food and Drug Administration record, read 2026-09-19, so there is no label naming who must avoid it and why.

The other place that answer usually comes from is a trial, which has to write down who it will not enrol. No registered study was found for this compound on 2026-09-19, so there is no exclusion list either.

Read this as missing information, not as a clear record. Nobody has published who is at risk, which is not the same as nobody being at risk.

What has not been published

Where a line above says nothing has been compiled here, that is a gap in this publication's record. Where it says nothing is indexed or registered, that is a gap in the public record.

Every row is a price read on that supplier's own site, divided by the milligrams it buys. Cheapest first, which is not a ranking of quality: the columns beside the rate show what this publication could confirm about the evidence behind it. Some supplier links here are referral links, marked where they appear, which pay Terminus Research when a reader buys. The same terms are open to every supplier in the ledger, apart from the one exception the referral policy page names, participation changes no score, rank, caution, or coverage decision, and a link is not an endorsement.

Vendor comparison

Per mgPriceSupplierCertificate checkableCaution on recordWhat the figure is
$7.00per mg $69.9510mg Koi Aminosrecord → not transcribed not transcribed single vial current price, single stated sizeread 2026-08-26
$9.00per mg $45.005mg ProPeptidesrecord → not checkable The certificate page contains no document, no lot, no figure and no laboratory name. single vial current priceread 2026-08-24
$12.00per mg $60.005mg Prime Labsrecord → not transcribed not transcribed single vial current price from catalog dataread 2026-08-26
$20.00per mg $40.002mg Polaris Peptidesrecord → not transcribed not transcribed single vial current priceread 2026-08-20

Read between 2026-08-20 and 2026-08-26. Prices move and these were read once.

Sources

Registered study counts, phases, lead sponsors and first-submitted dates: the clinicaltrials.gov public API, one intervention search on the term printed above, read 2026-09-19. Indexed paper counts and publication types: PubMed, the term printed above and that term narrowed by publication type, read 2026-09-19. Formula and computed mass: PubChem, the CID printed above, read 2026-09-19. Application status: the Food and Drug Administration Drugs@FDA database through the agency public endpoint, read 2026-09-19.

The dates in the paragraph above are the dates those fetches ran, stamped in UTC. The dates in the list below are the dates a person read each record. The same record can carry both, a day apart, when a fetch ran after midnight UTC.

ALL COMPOUNDS